Global Single Cell Genomics Market 2021 Comprehensive Research Methodology, Key Insights, Segments and Extensive Profiles by 2027 [MarketWatch]
10x Genomics, Inc. (TXG)
Last 10x genomics, inc. earnings: 2/18 04:01 pm
Check Earnings Report
Company Research
Source: MarketWatch
2021-2027 that depicts the present state of the industry, covering the key fundamentals of the market. The report reviews the market aspects of the industry like market size, market status, market trends, and forecast. The report then states definition, product portfolio, classification, and market segmentation based on type, application, and regions. The report covers the global Single Cell Genomics market analysis with in-depth analysis and portraying the current situation in the industry. The report concentrates on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. There is an in-depth section on opportunity mapping as well as barrier analysis. DOWNLOAD FREE SAMPLE REPORT: https://www.marketsandresearch.biz/sample-request/213053 Further, the report presents profiles of competitors in the market, key players include: 10X Genomics Accelerate Diagnostics Affymetrix Agilen
Show less
Read more
Impact Snapshot
Event Time:
TXG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TXG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TXG alerts
High impacting 10x Genomics, Inc. news events
Weekly update
A roundup of the hottest topics
TXG
News
- 10x Genomics (TXG) Upgraded to Buy: Here's What You Should Know [Yahoo! Finance]Yahoo! Finance
- 10x Genomics, Inc. (NASDAQ: TXG) had its price target lowered by analysts at Deutsche Bank Aktiengesellschaft from $60.00 to $55.00. They now have a "buy" rating on the stock.MarketBeat
- Vizgen Issued a New US Patent for Its MERFISH Technology [Yahoo! Finance]Yahoo! Finance
- 10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024PR Newswire
- 10x Genomics, Inc. (NASDAQ: TXG) had its price target lowered by analysts at Barclays PLC from $55.00 to $45.00. They now have an "overweight" rating on the stock.MarketBeat
TXG
Earnings
- 2/15/24 - Miss
TXG
Sec Filings
- 4/12/24 - Form PRE
- 3/25/24 - Form 4
- 3/25/24 - Form 4
- TXG's page on the SEC website